GANNON STEVEN (CIK 1643085) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Buy XENE (2,645 shares), Sell XENE (1,416 shares), Buy XENE (3,500 shares), Sell XENE (3 shares), Buy XENE (5,144 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Xenon Pharmaceuticals Inc. (XENE) | Director | Buy | 2,645 | $0 |
| 2026-06-03 | Xenon Pharmaceuticals Inc. (XENE) | Director | Sell | 1,416 | $75,629 |
| 2026-05-13 | Xenon Pharmaceuticals Inc. (XENE) | Director | Buy | 3,500 | $25,830 |
| 2025-06-06 | Xenon Pharmaceuticals Inc. (XENE) | Director | Sell | 3 | $91 |
| 2025-05-16 | Xenon Pharmaceuticals Inc. (XENE) | Director | Buy | 5,144 | $64,660 |
Source: SEC Form 4 filings · as of 2026-06-03